This inventor holds 9 USPTO granted patents and 7 published patent applications and 2 EPO patents. Top assignees: Caliper Life Sciences, Inc., Caliper Technologies Corporation, University of California. Active years: 2002-2015.
Location History:
- San Carlos, CA (US) (2002 - 2005)
- Los Altos, CA (US) (2006 - 2015)
Company Filing History:
4 out of 149 
4 out of 184 
1 out of 15,988 
Years Active: 2002-2015
Title: Innovations of Javier Anibal Farinas
Introduction
Javier Anibal Farinas is a notable inventor based in San Carlos, CA (US). He has made significant contributions to the field of microfluidics and proteomics, holding a total of 9 patents. His work focuses on developing methods and devices that enhance the efficiency of protein analysis.
Latest Patents
Among his latest patents is a method and apparatus for performing peptide digestion on a microfluidic device. This invention provides methods and apparatuses that allow a protein sample to undergo reduction, alkylation, and digestion in a continuous flow process carried out within a microfluidic device. These methods can be employed as part of an automated proteomics analysis carried out in an integrated proteomics system. Another significant patent is a microfluidic device with a filter, which includes a substrate, a flowpath with a well in fluid communication with a channel, and a filter disposed across the flowpath associated with the channel.
Career Highlights
Javier has worked with prominent companies in the field, including Caliper Technologies Corporation and Caliper Life Sciences, Inc. His experience in these organizations has contributed to his expertise in microfluidic technologies and proteomics.
Collaborations
Throughout his career, Javier has collaborated with notable professionals such as H Garrett Wada and Andrea W Chow. These collaborations have further enriched his work and innovations in the field.
Conclusion
Javier Anibal Farinas is a distinguished inventor whose contributions to microfluidics and proteomics have advanced the field significantly. His innovative patents and collaborations reflect his commitment to enhancing protein analysis technologies.